Israel Active

18 COVID-19 patients hospitalized with moderate or severe symptoms were treated with Amor-18 from Israel’s Amorphical (see previously). All recovered and were discharged in a few days.

Israel’s Binah.ai (see previously) has come a long way in the last 18 months. Some 50 million customers of the world’s top insurance companies now use Binah’s remote health and wellness monitoring platform to measure vital signs, from the changes in the reflection of light on facial skin.

Israel’s AiVF (see previously) has received regulatory approval to sell its IVF analysis platform product in the United Kingdom - one of the largest IVF markets in Europe. It can predict, without the need for a biopsy, whether a given embryo is genetically suitable for transfer.

The virtual reality simulator from Israel’s DecideVR identifies decision-making errors by doctors in medical treatment in intensive care units (ICU). The platform, developed by Professor Alex Mintz, formerly of Herzliya’s Reichman University, currently focuses on life-saving cardiovascular decisions.

Israel’s Nanox (see previously) has delivered the first of its next-generation X-ray machines to Israel’s Shamir Medical Center in Tzifrin. The Nanox.ARC uses low-radiation X-rays to produce high-resolution 3-D digital images, previously only available from expensive CT scans.

Scientists at Haifa University and the Technion Institute have found a link between bacteria in the gut and sleep patterns.  Those that eat fatty foods tend to be night owls, whereas those that have a high fiber diet tend to be early risers.

The partnership between Israel’s Datos Health and Israel’s Sheba Medical Center has progressed to at-home monitoring of babies born with complex heart malformations. Babies monitored include in the Palestinian Authority, Gaza, Iraq, Kurdistan, and Cyprus.

Israel’s ImmunoBrain Checkpoint (see previously) has been awarded a grant of $5 million over 3 years to support human clinical trials of IBC-Ab002, for the treatment of Alzheimer’s disease. Development was based on Weizmann Institute immune system studies.

Scientists at Israel’s Ben Gurion University have found that coronavirus patients have damaged mitochondria in the blood, but not in the lungs. They now urge a medical re-think, in that it is the immune system that needs treating and that antioxidants may be more effective than respiratory medications.

Tel Aviv University scientists have made progress in developing a treatment using the NAP peptide to counter Alzheimer’s and other neurological conditions (see previously). Their new compound dramatically decreased the excessive buildup of the protein tau, which misfolds in Alzheimer’s patients.